logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10329626 B1

PDFFull Text
Date of Patent:
Jun. 25, 2019

Filed:

Dec. 08, 2016

Nol3 is a predictor of patient outcome

Applicant:

Dana-farber Cancer Institute, Inc., Boston, MA (US);

Inventors:

Andrew Kung, Walpole, MA (US);

David Ziegler, Dover Heights, AU;

Assignee:

Dana-Farber Cancer Institute, Inc., Boston, MA (US);

Attorney:

Brinks Gilson & Lione

Primary Examiner:

Peter J Reddig

Int. Cl.
CPC ...
A61K 45/06 (2006.01); G01N 33/50 (2006.01); A61K 31/437 (2006.01); A61K 31/496 (2006.01); A61K 31/506 (2006.01); C07D 417/02 (2006.01); C12Q 1/6886 (2018.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 31/437 (2013.01); A61K 31/496 (2013.01); A61K 31/506 (2013.01); A61K 45/06 (2013.01); C07D 417/02 (2013.01); G01N 33/5044 (2013.01); G01N 33/57407 (2013.01); G01N 33/57484 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); G01N 2800/52 (2013.01); G01N 2800/7028 (2013.01);
Abstract

The present invention features a method for determining the prognosis for survival of a cancer patient. Methods for measuring the level of NOL3 expression in a cancer cell-containing sample from a patient, and comparing the level of NOL3 expression in the sample to a reference level of NOL3 expression are also included. A higher level of NOL3 relative to the reference level correlates with decreased survival of the patient, and an equivalent or lower level of NOL3 relative to the reference level correlates with increased survival of the patient.

Find Patent Forward Citations

Quick Actions:

Kung, Andrew. (2019). Nol3 is a predictor of patient outcome (U.S. Patent No. 10329626). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10329626

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…